Quetiapine: The Possibility of Quetiapine as a Cause of Neuroleptic Hypersensitivity in Dementia with Lewy Bodies

키워드

참고문헌 (12)

1. McKeith IG, "Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium", Neurology, 65, pp.1863~1872 (2005)
2. Lippa CF, "DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers", Neurology, 68, pp.812~819 (2007)
3. Swanberg MM, "Benefit-risk considerations in the treatment of dementia with Lewy bodies", Drug Safety, 25, pp.511~523 (2002)
4. Kang Y, "A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients", J Korean Neurol Assoc, 15, pp.300~307 (1997)
5. Choi SH, "Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale", J Korean Neurol Assoc, 19, pp.585~591 (2001)
6. Kang Y, "Seoul Neuropsychological Screening Battery (SNSB)" (2003), Human Brain Research & consulting Co.
7. Ballard C, "Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease", Am J Psychiatry, 156, pp.1039~1045 (1999)
8. Minister JB, "A comparison of extr. .apyramidal symptoms in older outpatients treated with quetiapine or risperidone", Curr Med Res Opin, 20, pp.1483~1491 (2004)
9. Baskys A, "Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms", J Clin Psychiatry, 65(11), pp.16~22 (2004)
10. Kobayashi A, "Ouetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report", Prog Neuropsychopharmacol Biol Psaychiatry, 30, pp.1170~1172 (2006)
11. McKeith I, "Neuroleptic sensitivity in patients with senile dementia of Lewy body type", BMJ, 305, pp.673~678 (1992)
12. Aarsland D, "Neuroleptic sensitivity in parkinson’s disease and parkinsonian dementias", J Clin Psychiatry, 66, pp.633~637 (2005)

관련 논문AI추천